药物对比
比较Acarbose与Miglitol治疗2型糖尿病。两者均抑制碳水化合物消化。主要差异：胃肠道副作用、给药方式及餐后血糖控制。
此页面暂无可用的对比维度。
临床背景
Selecting an alpha-glucosidase inhibitor for type 2 diabetes patients needing post-meal glucose control.
结论
Acarbose and miglitol show comparable efficacy for postprandial control, with choice driven by GI tolerance and cost.